Skip to main navigation
Skip to search
Skip to main content

MD Anderson Cancer Center Home

Help & FAQ

Home
Profiles
Research units
Equipment
Research output
Activities
Prizes

Search by expertise, name or affiliation

Ibrutinib and Venetoclax for First-Line Treatment of CLL. Reply

Nitin Jain, Varsha Gandhi, William Wierda

Leukemia
Experimental Therapeutics

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Overview
Fingerprint

Fingerprint

Dive into the research topics of 'Ibrutinib and Venetoclax for First-Line Treatment of CLL. Reply'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Powered by Pure, Scopus & Elsevier Fingerprint Engine™

All content on this site: Copyright © 2024 Elsevier B.V. or its licensors and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

About web accessibility

Report vulnerability